Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep MedicineApr 20, 2023

Testing one-time and reusable home devices measuring artery signals for diagnosing obstructive sleep apnea compared to lab sleep studies

GLP-1 Therapies Weekly Brief ↗PubMed ↗DOI ↗

Updated Mar 31, 2026

Abstract

Data from 100 participants indicated that both the disposable and reusable home sleep apnea tests showed satisfactory agreement with laboratory polysomnography for diagnosing obstructive sleep apnea.

The disposable home sleep apnea test (HSAT) had a mean bias of 2.04 events/hour for the apnea-hypopnea index (AHI) compared to laboratory polysomnography.
The reusable HSAT showed a mean bias of 2.91 events/hour for AHI when compared to laboratory polysomnography.
Oxygen desaturation index 3% mean bias was -0.21/hour for the disposable HSAT and 0.77/hour for the reusable HSAT.
Total sleep time agreement was satisfactory for the reusable HSAT with a mean bias of 4.18 minutes, but the disposable HSAT had a greater mean bias of 23.7 minutes due to high signal rejection.
Categorization of OSA severity yielded moderate agreement with laboratory PSG, with kappa values of 0.52 for the disposable HSAT and 0.57 for the reusable HSAT.

Simplified

STUDY OBJECTIVES: The objective of this study was to independently validate a disposable and a reusable home sleep apnea test (HSAT) recording on peripheral arterial tonometry, compared to laboratory polysomnography (PSG), for the diagnosis of obstructive sleep apnea (OSA).

METHODS: 115 participants undergoing PSG for suspected OSA were recruited and fitted with the two study devices (NightOwl, Ectosense, Belgium). After exclusions were applied and device failures were removed, data from 100 participants were analyzed. HSAT-derived apnea-hypopnea index (AHI), OSA severity category, total sleep time, and oxygen desaturation index 3% were compared to PSG.

RESULTS: Both study devices demonstrated satisfactory levels of agreement with minimal mean bias for determination of AHI and oxygen desaturation index 3% (disposable: AHI mean bias 2.04 events/h [95% limits of agreement -20.9 to 25.0], oxygen desaturation index 3% mean bias -0.21/h [-18.1 to 17.7]; reusable: AHI mean bias 2.91 events/h [-16.9 to 22.7], oxygen desaturation index 3% mean bias 0.77/h [-15.7 to 17.3]). Level of agreement diminished at higher AHI levels although misclassification for severe OSA occurred infrequently. Total sleep time level of agreement for the reusable HSAT was also satisfactory with minimal mean bias (4.18 minutes, -125.1 to 112.4), but the disposable HSAT was impacted by studies with high signal rejection (23.7 minutes, -132.7 to 180.1). Categorization of OSA severity demonstrated moderate agreement with laboratory PSG, with a kappa of 0.52 and 0.57 for the disposable and reusable HSATs respectively.

CONCLUSIONS: The two HSAT devices were comparable and performed well compared to laboratory PSG for the diagnosis of OSA.

CLINICAL TRIAL REGISTRATION: Registry: Australian New Zealand Clinical Trials Registry; Identifier: ANZCTR12621000444886.

CITATION: Lyne CJ, Hamilton GS, Turton ARE, et al. Validation of a single-use and reusable home sleep apnea test based on peripheral arterial tonometry compared to laboratory polysomnography for the diagnosis of obstructive sleep apnea.. 2023;19(8):1429-1435. J Clin Sleep Med

Funding

Competing interests

All authors have seen and approved the manuscript. The work in this manuscript was conducted at Monash Medical Centre, Monash Health. G.S.H. has received equipment to support research from ResMed, Philips Respironics, and Air Liquide Healthcare. Ectosense provided the study devices free of charge but had no role in the design, performance, or interpretation of the study. All other authors report no conflict of interest or financial support.

PubMed

Testing one-time and reusable home devices measuring artery signals for diagnosing obstructive sleep apnea compared to lab sleep studies

Abstract

Funding

Competing interests

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the glp-1 therapies brief

Abstract

Funding

Competing interests

Related papers

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the glp-1 therapies brief